CD4 and neoplasm: In a mesothelioma mouse model, a tumor-selective oncolytic vaccinia virus expressing CXCL11 reportedly enhanced tumor infiltrating CTLs and NK cells, but not CD4+ T cells, and prolonged survival (Liu et al., 2016).